Caxton Associates LP Abiomed Inc Transaction History

Caxton Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $57,980 - $87,369	258 Added 14.24%	2,070 $512,000
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $502,377 - $663,717	1,812 New	1,812 $600,000
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $321,994 - $422,021	-1,165 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $130,421 - $206,132	-464 Reduced 28.48%	1,165 $379,000
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $474,715 - $602,215	-1,339 Reduced 45.11%	1,629 $733,000
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $3,058 - $4,908	-11 Reduced 0.37%	2,968 $1.21 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $573,427 - $881,337	2,979 New	2,979 $867,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.